Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2019New England Journal of Medicine

Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAugusto VillanuevaNYU Langone Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Augusto Villanueva (2019) studied this question.

synapsesocial.com/papers/69d73bf78e958094d1b8a63dhttps://doi.org/10.1056/nejmra1713263
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival2003 · 3,044 citations
  2. 2Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma2018 · 259 citations
  3. 3Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–20302018 · 2,057 citations
  4. 4Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis2017 · 58 citations